Literature DB >> 4335821

[Autoradiographic studies on RNA metabolism during dibutylnitrosamime-induced bladder tumors in rats].

E Kunze, A Schauer, J Spielmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4335821     DOI： 10.1007/bf00304028

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN： 0084-5353


× No keyword cloud information.
  22 in total

1.  EXPERIMENTAL STUDIES ON THE BIOLOGICAL POTENTIAL OF BLADDER TUMORS.

Authors:  R J VEENEMA; B FINGERHUT; J K LATTIMER
Journal:  J Urol       Date:  1965-02       Impact factor: 7.450

2.  Bladder tumors and associated proliferative mucosal lesions.

Authors:  R B EISENBERG; R B ROTH; M H SCHWEINSBERG
Journal:  J Urol       Date:  1960-10       Impact factor: 7.450

3.  [Enzyme histochemical and radioautographic studies during cancerization of the rat liver with diethylnitrosamine].

Authors:  A Schauer; E Kunze
Journal:  Z Krebsforsch       Date:  1968

4.  [Enzyme-histochemical and autoradiographic studies on bladder papilloma induced by dibutyl nitrosamine in the rat].

Authors:  E Kunze; A Schauer
Journal:  Z Krebsforsch       Date:  1971

5.  Disorganization of mouse bladder epithelium induced by 2-acetylaminofluorene and 4-ethylsulfonylnaphthalene-1-sulfonamide.

Authors:  P E Levi; J C Knowles; D M Cowen; M Wood; E H Cooper
Journal:  J Natl Cancer Inst       Date:  1971-02       Impact factor: 13.506

6.  Pathogenesis, histology, and transplantability of urinary bladder carcinomas induced in albino rats by oral administration of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.

Authors:  E Ertürk; S M Cohen; J M Price; G T Bryan
Journal:  Cancer Res       Date:  1969-12       Impact factor: 12.701

7.  The carcinogenic action of 2-aminodiphenylene oxide and 4-aminodiphenyl on the bladder and liver of the C57 X IF mouse.

Authors:  D B Clayson; T A Lawson; J A Pringle
Journal:  Br J Cancer       Date:  1967-12       Impact factor: 7.640

8.  Hyperplasia of urinary tract epithelium induced by continuous administration by continuous administration of sulphonamide derivatives.

Authors:  K P SEN GUPTA
Journal:  Br J Cancer       Date:  1962-03       Impact factor: 7.640

9.  CORRELATION BETWEEN THE CHEMICAL INDUCTION OF HYPERPLASIA AND OF MALIGNANCY IN THE BLADDER EPITHELIUM.

Authors:  D B CLAYSON; T A LAWSON; S SANTANA; G M BONSER
Journal:  Br J Cancer       Date:  1965-06       Impact factor: 7.640

10.  THE INDUCTION OF TUMOURS OF THE MOUSE BLADDER EPITHELIUM BY 4-ETHYLSULPHONYLNAPHTHALENE-1-SULPHONAMIDE.

Authors:  D B CLAYSON; G M BONSER
Journal:  Br J Cancer       Date:  1965-06       Impact factor: 7.640
View more
  5 in total

1.  [Induction of lungtumors and tumors of the urinary bladder in rats by di-n-butyl nitrosamine in dimethyl sulfoxide].

Authors:  J Sander; G Bürkle; V Bürkle
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

2.  Focal loss of alkaline phosphatase and increase of proliferation in preneoplastic areas of the rat urothelium after administration of n-butyl-n-(4-hydroxybutyl)-nitrosamine and n-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide.

Authors:  E Kunze; A Schauer; G Krüsmann
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1975-10-27

Review 3.  [Stimulating effect of partial cystectomy on regeneration of rat bladder urothelium and its significance for carcinogenesis (author's transl)].

Authors:  E Kunze; H Albrecht; H H Wöltjen; A Schauer
Journal:  J Cancer Res Clin Oncol       Date:  1979-10       Impact factor: 4.553

4.  Stages of transformation in the development of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced transitional cell carcinomas in the urinary bladder of rats.

Authors:  E Kunze; A Schauer; S Schatt
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976

5.  Effect of dibutylnitrosamine and saccharin on glutamyl transpeptidase-positive foci and liver cancer.

Authors:  M A Pereira; S L Herren; A L Britt
Journal:  Environ Health Perspect       Date:  1983-04       Impact factor: 9.031
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.